Home › Funds › J. Goldman & Co LP › ENOV

J. Goldman & Co LP position in ENOV

ENOVIS CORPORATION · Health Care

J. Goldman & Co LP reported holding 901,115 shares of ENOV (ENOVIS CORPORATION) in its Q3 2026 13F filing — a position valued at US$16.5M, representing 0.66% of its reported portfolio and ranking #46 among its reported holdings. J. Goldman & Co LP has disclosed ENOV holdings in 3 of the last 7 reported quarters, going back to Q1 2025.

Latest position (Q3 2026)901.12K sh
Reported value held$16.46M
Portfolio Weight0.66%
First reportedQ1 2025
Last changeNew
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How J. Goldman & Co LP's ENOV position evolved

J. Goldman & Co LP first disclosed a stake in ENOV in Q1 2025 at 193,059 shares (US$7.4M). The position peaked in Q3 2026 at 901,115 shares, worth US$16.5M. Across 3 filings, J. Goldman & Co LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 901,115 shares valued at US$16.5M. Notable position changes include a 86% increase in Q2 2025 (shares fell 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 193.06K $7.38M New
Q2 2025 358.48K $11.24M Add
Q3 2026 901.12K $16.46M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ENOV and 13F data

ENOV (ENOVIS CORPORATION) is a Health Care company. 17 other funds we track also report a position in ENOV — the largest reported positions include Rubric Capital Management LP (US$80.7M), OAKTREE CAPITAL MANAGEMENT LP (US$37.8M), PRIVATE MANAGEMENT GROUP INC (US$32.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ENOV

All ENOV fund holders →

FAQ

How long has J. Goldman & Co LP held ENOV?

J. Goldman & Co LP has disclosed ENOV holdings in 3 of the last 7 reported quarters, going back to Q1 2025.

What is J. Goldman & Co LP's current position in ENOV?

As of Q3 2026, J. Goldman & Co LP holds 901.12K shares of ENOV (ENOVIS CORPORATION), valued at $16.46M, representing 0.66% of its reported portfolio and ranking #46.

Has J. Goldman & Co LP been buying or selling ENOV?

In the latest 13F filing (Q3 2026), J. Goldman & Co LP newly opened its position in ENOV. The position peaked in Q3 2026 at 901.12K shares.

Which other funds hold ENOV?

Other major institutional holders of ENOV include Rubric Capital Management LP, OAKTREE CAPITAL MANAGEMENT LP, PRIVATE MANAGEMENT GROUP INC, among 17 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.